JP Morgan Chase
TVGN icon

JP Morgan Chase’s Tevogen Bio Holdings TVGN Stock Holding History

JP Morgan Chase’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.06K Sell
479
-271
-36% -$3.32K ﹤0.01% 7009
2025
Q4 		$12.4K Buy
750
+249
+50% +$6.47K ﹤0.01% 6611
2025
Q3 		$19.7K Buy
501
+40
+9% +$1.97K ﹤0.01% 6479
2025
Q2 		$28.8K Sell
461
-1,009
-69% -$57.5K ﹤0.01% 6087
2025
Q1 		$79.4K Buy
1,470
+686
+88% +$45.1K ﹤0.01% 5681
2024
Q4 		$40.4K Buy
784
+334
+74% +$21.8K ﹤0.01% 6091
2024
Q3 		$8.29K Buy
450
+264
+142% +$7.72K ﹤0.01% 6400
2024
Q2 		$6.74K Buy
186
+185
+18,500% +$12.1K ﹤0.01% 6326
2024
Q1 		$112 Buy
+1
New +$362 ﹤0.01% 6889
2022
Q3 		– Sell
-1,000
Closed -$501K – 6917
2022
Q2 		$501K Sell
1,000
-2,832
-74% -$1.42M ﹤0.01% 4546
2022
Q1 		$1.91M Buy
+3,832
New +$1.91M ﹤0.01% 3795

Other funds holding TVGN

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

JP Morgan Chase's TVGN Position: Q1 2026 in Review

JP Morgan Chase reduced its Tevogen Bio Holdings (TVGN) stake by 36% in Q1 2026, selling an estimated $3.32K and leaving 479 shares worth $2.06K. The position accounts for ﹤0.01% of the portfolio, ranked #7009.

JP Morgan Chase first reported a position in TVGN in Q1 2022 and has held it in 11 quarters since. The position peaked at $1.91M in Q1 2022. 30 funds tracked by Wall St. Rank hold TVGN as of Q1 2026.

  • JP Morgan Chase held 479 shares of Tevogen Bio Holdings worth $2.06K as of Q1 2026.
  • JP Morgan Chase sold 271 Tevogen Bio Holdings shares in Q1 2026, an estimated $3.32K.
  • Tevogen Bio Holdings made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7009 holding.
  • JP Morgan Chase first reported a position in Tevogen Bio Holdings in Q1 2022 and has held it in 11 quarters since.
  • JP Morgan Chase's Tevogen Bio Holdings position peaked at $1.91M in Q1 2022.
  • 30 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.